linkedin

Press Releases

News Brief

Samsung Biologics receives the ‘Honor Award’ in the pharmaceutical sector from CDP Korea Awards

??.jpg
 

Today on January 26th (Wed), Samsung Biologics received the ‘Honor Award’ in the pharmaceutical sector from CDP Korea Awards as part of CDP (Carbon Disclosure Project), a non profit organization that runs the global disclosure system for investors, companies, cities, states and regions to manage their environmental impacts.

 

CDP runs the global environmental disclosure system and each year organizations measure, manage, and disclose their risks and opportunities on climate change, water security and deforestation in response to climate change and other environmental issues. 

 

First year involved in the disclosure, Samsung Biologics obtained the “Management” level which is the highest grade received in the pharmaceutical sector in Korea. The company received the CDP Korea Award as the first and only biopharmaceutical company, recognized for its continued efforts for decarbonization and eco-friendly management system. 

 

As a leading CDMO, Samsung Biologics is proactively participating in the global movement against climate change and has been engaging in a number of initiatives, including Frontier 1.5D, a collaborative project to develop a climate risk management model with various organizations, and Sustainable Markets Initiative, convened by His Royal Highness The Prince of Wales to decarbonize and lower emissions across industries.

 

The company also obtained two global ISO certifications for Environmental Management and Energy management in order to further fulfill its social responsibilities and successfully engage in initiatives related to ESG matters. 

??.jpg
 

Today on January 26th (Wed), Samsung Biologics received the ‘Honor Award’ in the pharmaceutical sector from CDP Korea Awards as part of CDP (Carbon Disclosure Project), a non profit organization that runs the global disclosure system for investors, companies, cities, states and regions to manage their environmental impacts.

 

CDP runs the global environmental disclosure system and each year organizations measure, manage, and disclose their risks and opportunities on climate change, water security and deforestation in response to climate change and other environmental issues. 

 

First year involved in the disclosure, Samsung Biologics obtained the “Management” level which is the highest grade received in the pharmaceutical sector in Korea. The company received the CDP Korea Award as the first and only biopharmaceutical company, recognized for its continued efforts for decarbonization and eco-friendly management system. 

 

As a leading CDMO, Samsung Biologics is proactively participating in the global movement against climate change and has been engaging in a number of initiatives, including Frontier 1.5D, a collaborative project to develop a climate risk management model with various organizations, and Sustainable Markets Initiative, convened by His Royal Highness The Prince of Wales to decarbonize and lower emissions across industries.

 

The company also obtained two global ISO certifications for Environmental Management and Energy management in order to further fulfill its social responsibilities and successfully engage in initiatives related to ESG matters. 

SITE MAP

close
Close

Thank you for Subscribing to Our Newsletter

아래 다운로드 버튼을 클릭하시면 바로 다운로드 하실 수 있습니다.

Close

Subscribe to Our Newsletter

파일 다운로드를 위해 뉴스레터 구독용 이메일 주소를 입력해주세요.
* 구독자라면 구독중인 이메일 주소를 입력해주세요.

뉴스레터 구독 서비스 유무 확인
Close

Subscribe to Our Newsletter

뉴스레터 구독 서비스를 등록하시면 당사 뉴스룸에서 제공되는
삼성바이오로직스의 최신 소식과 관심 분야별 유용한 정보를 받아 보실 수 있습니다.

Subscribe to Our Newsletter
    • - 개인정보 수집 목적 : 이메일 발신서비스 제공
    • - 개인정보 수집 항목 : 이메일 주소, 회사명, 이름, 직급, 국가
    • - 이용 및 보관 기간 : 이메일 발신서비스 해지 시까지

    개인정보 수집에 동의하지 않을 시, 뉴스레터 서비스를 이용할 수 없습니다.

    삼성바이오로직스 개인정보 보호정책에 따라 개인정보는 안전하게 관리됩니다.

close

SECURITY REPORT

Your valuable comments contribute to protecting Samsung Biologic’s core technology and management information, as well as reinforcing domestic competency and economic development.

  • This page is created for reporting core technology and management information leakage.
  • The reported contents as well as the identity of the reporter are strictly secured.
THE MANUAL FOR SECURITY NOTIFICATION

Copyright Samsung Biologics. All rights reserved